{
  "catalogId": "abaa4476-00f9-4a36-8cde-2829b802a7c0",
  "name": "TABRECTA 150 MG",
  "status": "",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "169 19 36653 99",
  "treatmentDescriptions": "TABRECTA is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have a mutation that leads to mesenchymal-epithelial transition (MET) exon 14 skipping as detected by an approved test.",
  "termsOfIssue": "Prescription required",
  "form": "film coated tablets",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "CAPMATINIB AS DIHYDROCHLORIDE MONOHYDRATE",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "L01EX17",
      "name": "CAPMATINIB"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "TABRECTA 150 MG 120 TAB",
      "manufacturer": {
        "name": "נוברטיס פארמה",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 120.0,
        "unit": "units"
      },
      "packagingDescription": "BLISTER PVC/PCTFE/AL",
      "shelfLife": "36",
      "storageConditions": "",
      "codes": {
        "moh": "9133",
        "yarpa": "18204",
        "pharmasoft": "17959"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 32826.91023,
        "retailMargin": 10.0,
        "maxRetailPrice": 36109.60125,
        "maxPriceWithVAT": 42609.32758
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-07-31T08:56:50.505440"
  }
}